Metabolic Dysfunction Associated Steatohepatitis Treatment Market: 2024 Global Future Scope, Ageing Population, Application, Industry Growth, Demand, Region, Competitive Analysis and Forecast 2031 | Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Red

Metabolic Dysfunction Associated Steatohepatitis Treatment Market Research Report By DataM Intelligence: A comprehensive analysis of current and emerging trends provides clarity on the dynamics of the Metabolic Dysfunction Associated Steatohepatitis Treatment market. The report employs Porter's Five Forces model to assess key factors such as the influence of suppliers and customers, risks posed by different entities, competitive intensity, and the potential of emerging entrepreneurs, offering valuable insights. Additionally, the report presents research data from various companies, including their benefits, gross margins, and strategic decisions in the global market, all conveyed through tables, charts, and infographics.

Download Free Sample PDF: https://datamintelligence.com/download-sample/metabolic-dysfunction-associated-steatohepatitis-treatment-market

What is the projected growth rate (CAGR) of the Global Metabolic Dysfunction Associated Steatohepatitis Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?

The Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market reached US$ 1.67 billion in 2023 and is expected to reach US$ 7.64 billion by 2031, growing at a CAGR of 21.8% during the forecast period 2024-2031.

What is Metabolic Dysfunction Associated Steatohepatitis Treatment Market?

Metabolic Dysfunction Associated Steatohepatitis (MASH) treatment refers to the medical and lifestyle interventions aimed at managing this liver condition characterized by fat accumulation, inflammation, and liver damage associated with metabolic dysfunction, including obesity, insulin resistance, and dyslipidemia.

Growth Driver

The global market for metabolic dysfunction-associated steatohepatitis (MASH) treatment is driven by the rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), which affects an estimated 30% of adults worldwide. This trend correlates with the increasing rates of obesity and related diseases. MASH, a severe form of MASLD, is linked to greater risks of fibrosis progression and is prevalent in a significant portion of patients undergoing liver biopsy. With MASH becoming a leading cause of adult liver transplantation in the U.S., the burden of MASLD and its complications, including hepatocellular carcinoma (HCC), is expected to grow significantly in the coming years.

Key Players:

Profiles of some of the major players in the global Metabolic Dysfunction Associated Steatohepatitis Treatment market, which include Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd., Thermo Fisher Scientific Inc., Biosynth, Affgility Solutions, Conscientia Industrial Co. Ltd., Smolecule Inc., 89 Bio Inc., and Sandoo Pharmaceuticals and Chemicals Co. Ltd.

Industry Development:

In August 2024, Altimmune reported that its experimental therapy, pemvidutide, significantly reduced liver fat, inflammation, and body weight in overweight or obese individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) during Phase I clinical trials. A Phase 2b trial, known as IMPACT (NCT05989711), is currently testing pemvidutide against a placebo in up to 190 adults with metabolic dysfunction-associated steatohepatitis (MASH).

In July 2024, researchers from Northwestern Polytechnical University and Air Force Medical University published a study indicating that phytic acid-based nanomedicine shows promise for treating MASH due to cerium's antioxidant, anti-inflammatory properties, and hepatophilicity.

Additionally, the role of monocyte-derived macrophages in MASH-associated liver fibrosis was explored, revealing that the long-chain saturated fatty acid-Egr2 pathway orchestrates the differentiation of these macrophages. The study identifies the transcription factor Egr2 as a key driver in the formation of hepatic lipid-associated macrophages (hLAMs) within MASH liver.

The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical information, market data that has been confirmed by the industry, and predictions based on a sound methodology. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Metabolic Dysfunction Associated Steatohepatitis Treatment market.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=metabolic-dysfunction-associated-steatohepatitis-treatment-market

Market Segments:

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Treatment: Drug, Therapy, Weight Management, Diabetes control, Regular Exercise, Foscarnet, Others
By End-User: Hospitals, Specialty Clinics, Homecare, Others

Regional Break out:

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Rest of South America

☞ Middle East and Africa

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/metabolic-dysfunction-associated-steatohepatitis-treatment-market

Key Features:

➧ Gain deep insights into market dynamics, trends, and opportunities to stay ahead in a competitive landscape.

➧ Track competitor's movements in real time, allowing you to swiftly adapt strategies and remain competitive.

➧ Compare your performance with industry leaders to identify gaps, strengths, and areas for improvement.

➧ Stay updated with emerging market trends, technological advancements, and customer behaviour to refine your strategy.

➧ Receive actionable insights and recommendations to drive your business toward growth and long-term success.

➧ Tailor competitive intelligence to your unique business needs, ensuring relevant and focused analysis.

➧ Evaluate supply chain efficiency and logistics strategies to optimize operations and minimize disruptions.

➧ Understand key players, stakeholders, and partnerships to navigate the competitive landscape more effectively.

➧ Identify and target specific market segments with detailed intelligence on customer preferences and behaviors.

➧ Stay informed on regulatory changes and legal requirements impacting your industry to ensure compliance and mitigate risks.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.